Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Controlled, Double-Blinded, Multi-Center, Phase 1/2b Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing
Conditions
Interventions
AM3101
Saline Placebo
Locations
3
United States
University of Cincinnati
Cincinnati, Ohio, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
Start Date
April 26, 2023
Primary Completion Date
January 1, 2026
Completion Date
June 1, 2027
Last Updated
December 17, 2025
NCT06541756
NCT06176183
NCT05985772
NCT06646536
NCT04572256
NCT05882591
Lead Sponsor
University of Cincinnati
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions